RNXT - RenovoRx, Inc.

QQQ $ 608.59 $ -9.26 (-1.5 %)

DIA $ 475.50 $ -6.59 (-1.37 %)

SPY $ 672.57 $ -8.41 (-1.24 %)

TLT $ 89.38 $ -0.42 (-0.46 %)

GLD $ 384.40 $ -4.31 (-1.11 %)

Previous Close

$ 0.9744

Open

$ 1.00

Bid

$ 0.90 x 686

Ask

$ 1.11 x 10

Day's Range

-- - --

52 Week Range

$ 0.75 - $ 1.69

Volume

606,669

Average Volume

Market Cap

35.71M

Beta (5Y Monthly)

$ 1.27

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-13-2025	09-30-2025	10-Q
2	08-14-2025	06-30-2025	10-Q
3	05-15-2025	03-31-2025	10-Q
4	04-01-2025	12-31-2024	10-K
5	11-13-2024	09-30-2024	10-Q
6	08-13-2024	06-30-2024	10-Q
7	05-10-2024	03-31-2024	10-Q
8	04-01-2024	12-31-2023	10-K
9	11-13-2023	09-30-2023	10-Q
10	08-16-2023	06-30-2023	10-Q
11	05-12-2023	03-31-2023	10-Q
12	03-31-2023	12-31-2022	10-K
13	11-14-2022	09-30-2022	10-Q
14	08-12-2022	06-30-2022	10-Q
15	05-13-2022	03-31-2022	10-Q
16	03-30-2022	12-31-2021	10-K
17	11-15-2021	09-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

RenovoRx Q3 EPS $(0.08), Inline, Sales $26...
11/13/2025 21:11:30

RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 pe...

Earnings Scheduled For November 13, 2025
11/13/2025 11:11:32

12 Health Care Stocks Moving In Monday's P...
11/10/2025 12:06:58

RenovoRx Completes First Registry-Eligible...
09/25/2025 12:32:53

First Registry-Eligible Patient Procedure Commenced at the University of Vermont Cancer CenterBaptist Health Miami Cancer Insti...

top-4-biotech-stocks-set-for-a-breakout-momentum-scores-surge

Top 4 Biotech Stocks Set For A Breakout: M...
09/08/2025 09:59:39

Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Ed...

12 Health Care Stocks Moving In Friday's I...
08/15/2025 17:07:19

12 Health Care Stocks Moving In Friday's P...
08/15/2025 12:10:02

RenovoRx Announces The Independent Data Mo...
08/14/2025 20:18:54

"At the same time, we are very excited to report that the independent Data Monitoring Committee (DMC) for our ongoing Phase...

RenovoRx Q2 EPS $(0.08) Beats $(0.09) Esti...
08/14/2025 20:12:52

RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 8...

Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

RenovoRx Expands RenovoCath Commercial Rea...
08/06/2025 12:38:18

RenovoRx increases its commercial footprint to thirteen leading National Cancer Institute-designated and community centers appr...

RenovoRx Launches PanTheR Post-Marketing R...
07/28/2025 12:36:50

Several Esteemed Cancer Centers to Commence Patient Enrollment Before the End of SeptemberThe Registry Study, Known as PanTheR,...

12 Health Care Stocks Moving In Friday's A...
06/27/2025 21:05:51

Ascendiant Capital Maintains Buy on Renovo...
06/05/2025 10:33:44

Ascendiant Capital analyst Edward Woo maintains RenovoRx (NASDAQ:RNXT) with a Buy and raises the price target from $11 to $1...

HC Wainwright & Co. Reiterates Buy on Reno...
05/19/2025 10:52:43

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates RenovoRx (NASDAQ:RNXT) with a Buy and maintains $3 price t...

RenovoRx Q1 EPS $(0.08) Beats $(0.09) Esti...
05/15/2025 20:07:04

RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 1...

Earnings Scheduled For May 15, 2025
05/15/2025 08:32:23

Earnings Preview For RenovoRx
05/14/2025 15:01:47

RenovoRx Secures New U.S. Patent For Renov...
05/06/2025 12:34:59

Patent Expands Protection of TAMP therapy platform, Including Methods to Deliver an Agent, such as a Chemotherapeutic Drug, Nea...

Johns Hopkins Medicine Initiates Enrollmen...
04/29/2025 12:37:33

Johns Hopkins Medicine's Valerie Lee, MD joins Michael J. Pishvaian, MD in an Appointed Key Role for TIGeR-PaC TrialBy beco...